Brooks Laboratories Ltd

NSE: BROOKS · BSE: 533543 · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹58.51
Market cap: ₹172.3 Cr
Revenue (annual): ₹85.74 Cr
Net profit (annual): ₹24.58 Cr
P/E (TTM): 13.1×Sector 47.4×
Promoter holding: 52.62%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Merger & Restructuring 2 Board Meeting Date 2 Debt & Borrowing 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Apr 2026 18:57 IST BSE

Debt & Borrowing

Brooks Laboratories Debt & Borrowing: ₹1.19 Cr

Brooks Laboratories Limited confirmed it does not qualify as a 'Large Corporate' for FY 2025-26 under SEBI debt-raising norms. The company reported outstanding borrowings of ₹1.19 Crore as of March 31, 2026. Its credit rating remains CARE BB; Stable / CARE A4 from CARE Ratings Limited.

Value: ₹1.19 Cr

Read the filing ↗